Scynexis (SCYX) Interest Coverage Ratio Growth (1y) (2014 - 2026)
Scynexis (SCYX) Interest Coverage Ratio Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.86 Bn | 42.90 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.19 Bn | 39.54 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.79 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.57 Bn | 22.77 Bn | 5.10 Bn | -83.16% |
| 5 | United Therapeutics | 22.15 Bn | 19.49 Bn | 683.80 Mn | 128.45% |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -97.39% |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.71 Bn | 11.18 Bn | 798.00 Mn | -8.29% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | Scynexis | 61.87 Mn | -52.82 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3,205.17% |
| Dec 31, 2025 | 185.08% |
| Sep 30, 2025 | -3,369.51% |
| Mar 31, 2025 | 9.44% |
| Dec 31, 2024 | -119.53% |
| Sep 30, 2024 | -1.72% |
| Jun 30, 2024 | -138.98% |
| Mar 31, 2024 | -251.38% |
| Dec 31, 2023 | 2,631.88% |
| Sep 30, 2023 | -201.29% |
| Jun 30, 2023 | 628.27% |
| Mar 31, 2023 | 64.13% |
| Dec 31, 2022 | 122.01% |
| Sep 30, 2022 | 17.14% |
| Jun 30, 2022 | 55.12% |
| Mar 31, 2022 | -373.22% |
| Dec 31, 2021 | -154.46% |
| Sep 30, 2021 | 81.11% |
| Jun 30, 2021 | -100.28% |
| Mar 31, 2021 | 87.23% |